ARES LIFE SCIENCES
Ares Life Sciences AG is a venture capital firm specializing in expansion and late stage investments. The firm seeks to invest in life sciences sector with a focus on pharmaceuticals, biotechnology, diagnostics, medical technology, and healthcare services. In pharmaceuticals, it seeks to invest in innovative drugs, generics, and specialty to OTC. In biotechnology, it seeks to invest in in novel biological products and biosimilars.
ARES LIFE SCIENCES
Industry:
Venture Capital
Founded:
2008-01-01
Status:
Active
Contact:
+41 58 944 04 00
Similar Organizations
Freigeist Capital
Freigeist is a venture capital fund specialized on deep tech seed stage investments.
Excalibur Fund Managers
Excalibur Fund Managers is a venture capital firm specializing in early, mid, and late stage investments.
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm specializing in investments in start-up, early stage, mid venture, late venture.
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-10-06 | Affidea | Affidea acquired by Ares Life Sciences | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2008-12-05 | Broncus Technologies | Ares Life Sciences investment in Series G - Broncus Technologies | 38 M USD |
2008-11-06 | Santhera Pharmaceuticals | Ares Life Sciences investment in Post-IPO Equity - Santhera Pharmaceuticals | 15.9 M CHF |
More informations about "Ares Life Sciences"
Ares Life Sciences AG
Jan 1, 2008 Its strategy is to focus on key life sciences sectors, mainly: pharmaceuticals and biotechnology, medical diagnostics, and medical technology. Ares Life Sciences has a long โฆSee details»
Ares Life Sciences - Crunchbase Investor Profile & Investments
Ares Life Sciences AG is a venture capital firm specializing in expansion and late stage investments. The firm seeks to invest in life sciences sector with a focus on pharmaceuticals, โฆSee details»
Ares Life Sciences to Acquire GREER(R) Laboratories, Inc., a Leader โฆ
Mar 8, 2013 Ares Life Sciences, a healthcare-focused investment group, announced today that it has signed a definitive agreement to acquire 100% of the share capital of Albion Medical โฆSee details»
Ares Life Sciences I S.à r.l. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ares Life Sciences I S.à r.l. of Luxembourg. Get the latest business insights from Dun & Bradstreet.See details»
Ares Life Sciences - Investments, Portfolio & Company Exits
Ares Life Sciences 's most notable exits include Santhera Pharmaceuticals and Broncus Technologies. Which industries has this organization had the most exits in? Show . Santhera โฆSee details»
B-FLEXION (former Ares Life Sciences) - BioAlps
B-FLEXION is a private, entrepreneurial investment firm with offices across Europe and in the US. B-FLEXION invests in โ and partners with โ asset managers across sectors including Private โฆSee details»
Ares Life Sciences Fund: Performance - PitchBook
Ares Life Sciences Fund is a 2008 vintage later stage venture capital fund managed by Ares Life Sciences. The fund is located in Geneva, Switzerland. The fund targeted healthcare services โฆSee details»
Antigen Laboratories, Inc. to be Acquired by Ares Life Sciences
Apr 15, 2013 About Ares Life Sciences. Ares Life Sciences is a healthcare-focused investment group, whose financial backer is the Bertarelli family. Its strategy is to focus on key life โฆSee details»
Ares Life Sciences SA - Company Profile and News
Company profile page for Ares Life Sciences SA including stock price, company news, executives, board members, and contact informationSee details»
Ares Life Sciences SA - VentureRadar
Peaccel France Privately Held PEACCEL โThe AI company for Life Sciencesโ offers an innovative unique and versatile AI-platform named innovโSAR that allows predicting multiple types of โฆSee details»
Ares Life Sciences - Tech Stack, Apps, Patents & Trademarks
Ares Life Sciences is a venture capital firm specializing in expansion and late stage investments.See details»
Wendel gives exclusivity to Ares Life Sciences to acquire its stake โฆ
About Ares Life Sciences: Ares Life Sciences is a healthcare-focused investment firm, whose financial backer is the Bertarelli family. Its strategy is to focus on key life sciences sectors, โฆSee details»
Ares Life Sciences - BioCentury Company Profiles - BCIQ
Apr 6, 2015 Ares Life Sciences - BioCentury Company Profiles for the biopharma industrySee details»
Ares Life Sciences to acquire US-based Antigen Laboratories
Apr 15, 2013 Ares Life Sciences, a Swiss healthcare-focused investment group, has agreed to acquire Planet Biopharmaceuticals, including its subsidiary Antigen Laboratories, a producer โฆSee details»
Ares Life Sciences โ Investors Database โ Unicorn Nest
In 2008 was created Ares Life Sciences, which is appeared as VC. The main department of described VC is located in the Geneva. The venture was found in Europe in Switzerland. The โฆSee details»
Ares Life Sciences - Updates, News, Events, Signals & Triggers
Ares Life Sciences is a venture capital firm specializing in expansion and late stage investments.See details»
Ares Life Sciences to Acquire Antigen Laboratories, Inc., in the โฆ
Apr 15, 2013 Ares Life Sciences, a healthcare-focused investment group, announced today that it has signed a definitive agreement to acquire 100% of the share capital of Planet โฆSee details»
Recommended Cash Acquisition of Stallergenes Greer PLC by Ares โฆ
Mar 21, 2019 The special committee of independent directors of Stallergenes Greer (Paris:STAGR) (the "Special Committee") and Ares Life Sciences I S.à r.l. ("Waypoint") are โฆSee details»
Ares Trading S.A. - Life-Sciences-Europe.com
Jan 1, 1995 Business Parks & Science Centres. Nerviano Bio-Park (Bioparco di Nerviano) Biocitech SAS; Genopole (GIP Genopole) Biopôle S.A. (Lausanne) Utrecht Science Park โฆSee details»
Ares Life Sciences acquires Affidea - 2014-10-06 - Crunchbase
Oct 6, 2014 Acquired Organization: Affidea Affidea, the Pan-European provider of diagnostic imaging and cancer treatment services. Acquiring Organization: Ares Life Sciences Ares Life โฆSee details»